TipRanks
Go Ultimate55% OFF

STX Corporation (011810) Price & Analysis

011810 Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
KRW 109.36B
Enterprise Value
KRW 401.61B
Total Cash (Recent Filing)
KRW 37.26B
Total Debt (Recent Filing)
KRW 321.84B
Price to Earnings (P/E)
―
Beta
1.20
Next Earnings
Nov 12, 2026
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recent Cash Generation

Positive operating and free cash flow in both 2024 and 2025 provides an internal funding source despite reported losses. If maintained, this cash generation could support operations and rehabilitation execution, although historical volatility means it is not yet a proven durable trend.

Court-Approved Rehabilitation

Court approval gives STX a formal, legally supported restructuring framework rather than leaving recovery dependent on ad hoc actions. This creates a defined process for capital restructuring and oversight, potentially improving the company’s ability to address financial distress over the next several quarters.

Debt-Claim Reduction

Reducing approximately KRW 348.8 billion of rehabilitation claims through a debt-for-equity swap could materially lower obligations and improve the capital structure. Although it brings no cash inflow and future conversions remain possible, it is a concrete balance-sheet cleanup step within the approved plan.

Bears Say

Persistent Losses And Revenue Decline

Net losses in every reported year, a 2025 net margin around -26%, and a steep 2025 revenue decline point to weakness in the underlying earnings model. Thin gross margins provide little protection against cost volatility, making a durable return to profitability difficult without operational improvement.

Negative Equity And High Leverage

Shareholders’ equity turned negative in 2025 while leverage remained large relative to the capital base. This weakens creditor protection, raises refinancing and solvency risk, and limits financial flexibility for investment or absorbing further operating setbacks during rehabilitation.

KOSPI Delisting Risk

STX has been deemed to meet KOSPI delisting criteria and must await a further review after objecting. An adverse decision could reduce market access and liquidity, complicate stakeholder confidence, and add a continuing regulatory constraint while the rehabilitation plan is implemented.

STX Corporation News

011810 FAQ

What is STX Corporation’s market cap?
STX Corporation’s market cap is ₩109.36B.
When is STX Corporation’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were STX Corporation’s earnings last quarter?
STX Corporation released its earnings results on Aug 14, 2026. The company reported -$1,842.799 earnings per share for the quarter.
Is STX Corporation overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does STX Corporation pay dividends?
STX Corporation pays a ― dividend of $66,106.133 which represents an annual dividend yield of ―. See more information on STX Corporation dividends here
What is STX Corporation’s EPS estimate?
STX Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does STX Corporation have?
STX Corporation has 31,017,927 shares outstanding.
What happened to STX Corporation’s price movement after its last earnings report?
STX Corporation reported an EPS of -$1,842.799 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of STX Corporation?
Currently, no hedge funds are holding shares in KR:011810
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology